Back to Newsroom

StemCells, Inc. Reports Third Quarter 2014 Financial and Operating Results

NEWARK, Calif., Nov. 5, 2014 (GLOBE NEWSWIRE) — StemCells, Inc.(Nasdaq:STEM), which pioneered the discovery and development of HuCNS-SC®cells, a proprietary population of highly purified, expandable human neural stem cells and is leading the development of cell based therapies for the treatment of disorders of the central nervous system, today reported financial results for the third quarter ended September 30, 2014.

Click here to read more